Certified Diabetes Educator Practice Exam 2026 - Free Practice Questions and Study Resource.

Pramlintide is classified as an amylin analog. Amylin is a hormone that is co-secreted with insulin by the pancreas and plays a crucial role in glucose regulation. By mimicking the action of amylin, pramlintide helps to control postprandial glucose levels through several mechanisms, including slowing gastric emptying, promoting satiety, and inhibiting glucagon secretion.

This specific action on the corresponding receptors allows for better glycemic control in patients with diabetes, particularly type 1 and type 2 diabetes, when used in conjunction with insulin. Understanding the role of pramlintide as an amylin analog is vital for diabetes management strategies, particularly when focusing on therapies that can complement insulin therapy.

The other options refer to different classes of medications that do not share the action or mechanism of pramlintide. Insulin analogs are modified forms of insulin that have altered pharmacokinetic properties, SGLT2 inhibitors work by preventing glucose reabsorption in the kidneys, and GLP-1 receptor agonists enhance insulin secretion and lower the glucagon release. Each of these classes has distinct mechanisms of action and therapeutic uses, making it essential to recognize pramlintide specifically as an amyl